Radioimmunoassay Market is Likely to Grasp the Value of USD 618.44 Million by 2030, Size, Share, Growth Drivers, Trends, Challenges and Competitive Landscape
LONDON, Jan. 24, 2023 /PRNewswire/ -- Data Bridge Market Research has recently published a Report, titled, "Radioimmunoassay Market" The report offers an extensive analysis of key growth strategies, drivers, opportunities, key segment, Porter's Five Forces analysis, and competitive landscape. The universal Radioimmunoassay business report encompasses a thorough study of current situation of the global market along with several market dynamics Competitor analysis is one of the most important aspects of market research report which helps businesses decide upon the strategies by comparing them with the competitors. The use of newest and advanced tools and techniques used for this report makes it the finest in the class. Competitor strategies highlighted in the winning Radioimmunoassay market survey report mainly include new product launches, expansions, agreements, joint ventures, partnerships, acquisitions, and others that boost their footprints in this market.
The global radioimmunoassay market is expected to grow in the forecast period of 2023 to 2030. Data Bridge Market Research analyses that the market is growing with a CAGR of 4.1% in the forecast period of 2023 to 2030 and is expected to reach USD 618.44 million by 2030.
Download Sample Copy of Radioimmunoassay Market @ https://www.databridgemarketresearch.com/request-a-sample/?dbmr=global-radioimmunoassay-market
Radioimmunoassay is a heterogeneous assay that employs a radiolabeled drug (typically 125i), the competitive binding assay theory that underpins radioimmunoassay. In this method, antigen and antibody bind to one another, and radioimmunoassay is used to determine how much antigen is bound. With the aid of antibodies, this method's hypersensitivity allows it to detect even the tiniest hormone or medication levels.
Due to the rise in healthcare prevalence of various diseases, increased research in the healthcare sector for therapeutic purposes, and various testing like endocrinology and infectious diseases by using radioimmunoassay kits used for testing and increasing healthcare spending would also propel business growth. The clinical research and laboratories for pre-testing various diseases allow the market to expand.
Opportunities for Players:
- LACK OF SKILLED PROFESSIONALS
The radioimmunoassay technique is very advanced and sensitive enough to find small molecules in the blood. It is therefore used for research purposes and diagnosing diseases such as cancer. Organizations and research labs also implement this technique for specific research purposes that use animal or human serum. However, the lack of qualified personnel who cannot use these instruments could curb the growth of the radioimmunoassay market over a forecast period.
Moreover, rapid technological advancement in this field also led to the lack of skilled professionals. Lack of skilled professionals poses a major challenge while handling device devices worldwide.
Some of the major players operating in the Radioimmunoassay market are:
- PerkinElmer Inc.,
- Merck KGaA,
- Beckman Coulter, Inc.,
- Abcam Plc.,
- Tecan Trading AG,
- EUROIMMUN Medizinische Labordiagnostika AG,
- KAMIYA BIOMEDICAL COMPANY,
- Berthold Technologies GmbH & Co.KG,
- Demeditec Diagnostics GmbH,
- MyBioSource.com.,
- DiaSource,
- Hidex Oy.,
- MP BIOMEDICALS, and
- Immuno-Biological Laboratories
Get Full PDF Research Report to Understand More @ https://www.databridgemarketresearch.com/checkout/buy/enterprise/global-radioimmunoassay-market
Recent Developments
- In April 2022, Merck, a leading science and technology company, announced several organizational changes and a new operating model to support the life science business sector's long-term growth strategy and better serve its customers' evolving needs. This has helped the company to expand its life sciences business segment.
- In June 2022, EUROIMMUN, a PerkinElmer, Inc. company, announced the launch of two CE-marked assays – the Anti-SARS-CoV-2 RBD ChLIA (IgG) and the Anti-SARS-CoV-2 Omicron ELISA (IgG). Both test systems enable the detection of IgG antibodies formed against SARS-CoV-2 and are available to laboratories in countries that accept the CE mark. This has helped the company to expand its business in the market.
The report provides insights on the following pointers:
Market Penetration: Comprehensive information on the product portfolios of the top players in the Radioimmunoassay market
Product Development/Innovation: Detailed insights on upcoming technologies, R&D activities, and product launches in the market
Competitive Assessment: In-depth assessment of the market strategies, and geographic and business segments of the leading players in the market
Market Development: Comprehensive information about emerging markets. This report analyzes the market for various segments across geographies
Market Diversification: Exhaustive information about new products, untapped geographies, recent developments, and investments in the Radioimmunoassay Market
Market Dynamics: Radioimmunoassay Market
- Increase In The Demand For Error-Free And Accurate Results Of High Throughput And Automated Procedures
Radioimmunoassay is a heterogeneous assay that employs a radiolabeled drug (typically 125i), the competitive binding assay theory that underpins radioimmunoassay. In this method, antigen and antibody bind to one another, and radioimmunoassay is used to determine how much antigen is bound.
Therefore, due to the increasing number of such severe diseases and viruses, the growth of biological models has been largely seen in recent years. This has increased the demand for error-free and accurate results from biological samples.
- Rise In The Prevalence And Incidence Of Infectious Diseases
Infectious diseases are illnesses caused by harmful agents (pathogens) entering the body. The most common causes are viruses, bacteria, fungi, and parasites. Infectious diseases usually spread from person to person through contaminated food or water and bug bites. Some infectious diseases are minor, and some are very serious.
Thus, rising number of cases of infectious, the growth of biological models has been largely seen in recent years. This has led to increased demand for various radioimmunoassay techniques for detecting and studying these aspects, which is expected to drive the market's growth in the coming years.
A comprehensive analysis will be provided covering the following points in the report:
- Executive Market Summary
- Scope of the Radioimmunoassay Report
- Key Finding and Recommendations
- Growth and Investment Opportunities
- Radioimmunoassay Market Value Chain/Supply Chain Analysis
- Radioimmunoassay Market Attractive Investment Proposition
- Competitive landscape and SWOT Analysis
- Radioimmunoassay Market Segmentation Outlook
- Regional Outlook
- Company Profiles of Key Players
Porter's five forces model in the report provides insights into the competitive rivalry, supplier and buyer positions in the market and opportunities for the new entrants in the global Radioimmunoassay market over the period. Further, Growth Matrix gave in the report brings an insight into the investment areas that existing or new market players can consider.
To Gain More Insights about this Research, Visit @ https://www.databridgemarketresearch.com/reports/global-radioimmunoassay-market
Key Industry Segmentation: Radioimmunoassay Market
By Product Type
- Radio Immunoassay Reagents and Kits
- Radio Immunoassay Analyzer
By Application
- Clinical Diagnosis
- Scientific Research
By End user
- Hospitals
- Clinical Diagnostic Laboratories
- Academic And Research Institutes
- Pharmaceutical And Biopharmaceutical Industry
- Contract Research Organizations
By Distribution Channel
- Direct Tender
- Online Sales
- Third Party Distributions
Regional Analysis/Insights: Radioimmunoassay Market
The countries covered in this radioimmunoassay market report are U.S., Canada, Mexico, Germany, France, U.K., Italy, Spain, Russia, Turkey, Netherlands, Belgium, Switzerland, rest of Europe, China, Japan, India, South Korea, Australia, Indonesia, Philippines, Thailand, Malaysia, Singapore, rest of Asia-Pacific, Brazil, Argentina, rest of South America, South Africa, Saudi Arabia, UAE, Egypt, Israel, and rest of Middle East and Africa.
North America dominates the global radioimmunoassay market regarding market share and revenue and will continue to flourish its dominance during the forecast period. This is due to the rising technological advancements in microscopy in that region, and growing R&D investments and the launch of new products are boosting the market.
Table of Contents:
- Introduction
- Market Segmentation
- Executive Summary
- Premium Insights
- Global Radioimmunoassay Market: Regulations
- Market Overview
- Global Radioimmunoassay Market, By Product Type
- Global Radioimmunoassay Market, By Application
- Global Radioimmunoassay Market, By End User
- Global Radioimmunoassay Market, By Distribution Channel
- Global Radioimmunoassay Market, By Region
- Global Radioimmunoassay Market: Company Landscape
- SWOT Analyses
- Company Profile
- Questionnaires
- Related Reports
To Check the Complete Table of contents, click here @ https://www.databridgemarketresearch.com/toc/?dbmr=global-radioimmunoassay-market
Explore More Reports:
Middle East and Africa Radioimmunoassay Market, By Product Type (Radio Immunoassay Reagents and Kits and Radio Immunoassay Analyser), Application (Scientific Research and Clinical Diagnosis), End User (Hospitals, Clinical Diagnostic Laboratories, Academic and Research Institutes, Pharmaceutical and Biopharmaceutical Industry, Contract Research Organizations, and Other), Distribution Channel (Direct Tender, Online Sales, Third Party Distribution, and Others) https://www.databridgemarketresearch.com/reports/middle-east-and-africa-radioimmunoassay-market
North America Radioimmunoassay Market, By Product Type (Radio Immunoassay Reagents and Kits and Radio Immunoassay Analyser), Application (Scientific Research and Clinical Diagnosis), End User (Hospitals, Clinical Diagnostic Laboratories, Academic and Research Institutes, Pharmaceutical and Biopharmaceutical Industry, Contract Research Organizations, and Other), Distribution Channel (Direct Tender, Online Sales, Third Party Distribution, and Others) https://www.databridgemarketresearch.com/reports/north-america-radioimmunoassay-market
Europe Radioimmunoassay Market, By Product Type (Radio Immunoassay Reagents and Kits and Radio Immunoassay Analyser), Application (Scientific Research and Clinical Diagnosis), End User (Hospitals, Clinical Diagnostic Laboratories, Academic and Research Institutes, Pharmaceutical and Biopharmaceutical Industry, Contract Research Organizations, and Other), Distribution Channel (Direct Tender, Online Sales, Third Party Distribution, and Others) https://www.databridgemarketresearch.com/reports/europe-radioimmunoassay-market
Asia-Pacific Radioimmunoassay Market, By Product Type (Radio Immunoassay Reagents and Kits and Radio Immunoassay Analyser), Application (Scientific Research and Clinical Diagnosis), End User (Hospitals, Clinical Diagnostic Laboratories, Academic and Research Institutes, Pharmaceutical and Biopharmaceutical Industry, Contract Research Organizations, and Other), Distribution Channel (Direct Tender, Online Sales, Third Party Distribution, and Others) https://www.databridgemarketresearch.com/reports/asia-pacific-radioimmunoassay-market
STD Diagnostics Market, By Type (Chlamydia Testing, Syphilis Testing, Gonorrhea Testing, Herpes Simplex Virus Testing, Human Papilloma Virus Testing, Human Immunodeficiency Virus Testing), Testing (Laboratory Devices, Point of Care Devices), Testing Devices (Thermal Cyclers, PCR, Lateral Flow Readers - Immunochromatographic Assays, Flow Cytometers, Differential Light Scattering Machines, Absorbance Microplate Reader, Phone Chips, Rapid Diagnostic Kits), End-User (Hospitals, Others), Country https://www.databridgemarketresearch.com/reports/global-std-diagnostics-market
Medical Supplies Market, By Type (Diagnostic Supplies, Dialysis Consumables, Inhalation Products, Wound Care Consumables, Radiology Consumables, Infection Control Supplies, Infusion Products, Intubation and Ventilation Supplies, Personal Protection Equipment (PPE), Hypodermic Products, Sterilization Consumables, Other Medical Supplies), Application (Urology, Wound Care, Radiology, Anaesthesia, Sterilization, Cardiology, Ophthalmology, Other Applications), End User (Hospitals, Clinics/Physician Offices, Assisted Living Centres and Nursing Homes, Ambulatory Surgery Centres, Other End Users) https://www.databridgemarketresearch.com/reports/global-medical-supplies-market
Monkeypox Market, By Treatment (Cidofovir, Brincidofovir, Tecovirimat, Vaccinia ImmuneGlobulin), End-Users (Clinics, Hospitals, Others), Distribution Channel (Direct Tender, Hospital Pharmacy, Retail Pharmacy, Online Pharmacy, Others) https://www.databridgemarketresearch.com/reports/global-monkeypox-market
Breast Reconstruction Market, By Product (Breast Implants, Tissue Expanders, Acellular Dermal Matrix), Type (Unilateral Breast Reconstruction, Bilateral), Shape (Round Implants, Anatomical Implants), Technology (Inframammary, Peri-Areolar, Trans-Axillary, Transumbilical), Placement (Dual-Plane Insertion, Subglandular Insertion, Submuscular Insertion), Procedure (Immediate Procedures, Delayed Procedures, Revision Procedures), End User (Hospitals, Cosmetology Clinics, Ambulatory Surgical Centers, Others), Country (U.S., Canada, Mexico, Germany, Italy, U.K., France, Spain, Netherland, Belgium, Switzerland, Turkey, Russia, Rest of Europe, Japan, China, India, South Korea, Australia, Singapore, Malaysia, Thailand, Indonesia, Philippines, Rest of Asia- Pacific, Brazil, Argentina, Rest of South America, South Africa, Saudi Arabia, UAE, Egypt, Israel, Rest of Middle East & Africa) https://www.databridgemarketresearch.com/reports/global-breast-reconstruction-market
Medical Bed Market, By Product (Acute Care Beds, MedSurg Beds, ICU Beds, Pediatric Beds, Birthing Beds, Long-term Care Beds, Psychiatric Care Beds, Bariatric Care Beds and Others), Application (Intensive Care and Non Intensive), Type (Electric Beds, Semi Electric Bed and Manual Bed), End User (Hospital, Home Care and Elderly Care) https://www.databridgemarketresearch.com/reports/global-medical-bed-market
About Data Bridge Market Research:
An absolute way to forecast what future holds is to comprehend the trend today!
Data Bridge Market Research set forth itself as an unconventional and neoteric Market research and consulting firm with unparalleled level of resilience and integrated approaches. We are determined to unearth the best market opportunities and foster efficient information for your business to thrive in the market. Data Bridge endeavours to provide appropriate solutions to the complex business challenges and initiates an effortless decision-making process. Data Bridge is an aftermath of sheer wisdom and experience which was formulated and framed in the year 2015 in Pune.
Data Bridge Market Research has over 500 analysts working in different industries. We have catered more than 40% of the fortune 500 companies globally and have a network of more than 5000+ clientele around the globe. Data Bridge adepts in creating satisfied clients who reckon upon our services and rely on our hard work with certitude. We are content with our glorious 99.9 % client satisfying rate.
Contact Us:
Data Bridge Market Research
US: +1 888 387 2818
UK: +44 208 089 1725
Hong Kong: +852 8192 7475
Email: corporatesales@databridgemarketresearch.com
Logo: https://mma.prnewswire.com/media/1011053/Data_Bridge_Market_Research_Logo.jpg
Share this article